Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-21
2009-08-25
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S124000
Reexamination Certificate
active
07579361
ABSTRACT:
Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
REFERENCES:
patent: 2800478 (1957-07-01), Zirkle
patent: 2800481 (1957-07-01), Zirkle
patent: 3634852 (1972-01-01), Hartley et al.
patent: 5590645 (1997-01-01), Davies et al.
patent: 5860419 (1999-01-01), Davies et al.
patent: 5873360 (1999-02-01), Davies et al.
patent: 6248752 (2001-06-01), Smith
patent: 6262066 (2001-07-01), Tulshian et al.
patent: 6350758 (2002-02-01), Kozikowski et al.
patent: 6455527 (2002-09-01), Tulshian et al.
patent: 6696462 (2004-02-01), Eickmeier et al.
patent: 6750226 (2004-06-01), Forner et al.
patent: 7276521 (2007-10-01), Busch-Petersen et al.
patent: 2005/0020660 (2005-01-01), Guyaux et al.
patent: 2005/0113417 (2005-05-01), Mammen et al.
patent: 2005/0209272 (2005-09-01), Fernandez et al.
patent: 2006/0160844 (2006-07-01), Belmonte et al.
patent: 2006/0178395 (2006-08-01), Belmonte et al.
patent: 2006/0178396 (2006-08-01), Belmonte et al.
patent: 2006/0211758 (2006-09-01), Busch-Peterson et al.
patent: 2007/0105895 (2007-05-01), Busch-Peterson et al.
patent: 2007/0129396 (2007-06-01), Wan et al.
patent: 2007/0238752 (2007-10-01), Busch-Petersen et al.
patent: 0069715 (1982-06-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2242134 (1991-09-01), None
patent: 87/05213 (1987-09-01), None
patent: 2004/012684 (2004-02-01), None
patent: 2006/050239 (2006-05-01), None
patent: 2006/055503 (2006-05-01), None
patent: 2006/055553 (2006-05-01), None
patent: 2006/062883 (2006-06-01), None
patent: 2006/062931 (2006-06-01), None
patent: 2006/065755 (2006-06-01), None
patent: 2006/065788 (2006-06-01), None
patent: 2007/016639 (2007-02-01), None
patent: 2007/016650 (2007-02-01), None
patent: 2007/018508 (2007-02-01), None
patent: 2007/018514 (2007-02-01), None
patent: 2007/022351 (2007-02-01), None
Zirkle et al., Journal of Medicinal & Pharmaceutical Chemistry (1962), 5, 341-56.
Lutz Waldemar et al., International journal of occupational medicine and environmental health, (2004) vol. 17, No. 4, pp. 417-31.
U.S. Appl. No. 10/575,837, filed Apr. 13, 2006, Palovich, et al.
U.S. Appl. No. 10/577,834, filed May 1, 2006, Wan, et al.
U.S. Appl. No. 10/581,230, filed Mar. 17, 2007, Busch-Peterson, et al.
U.S. Appl. No. 10/581,229, filed Mar. 15, 2007, Busch-Peterson, et al.
U.S. Appl. No. 10/585,830, filed Jul. 12, 2006, Laine, et al.
U.S. Appl. No. 10/598,743, filed Sep. 11, 2006, Budzik, et al.
U.S. Appl. No. 10/598,750, filed Sep. 11, 2006, Jin, et al.
U.S. Appl. No. 10/598,888, filed Sep. 14, 2006, Busch-Peterson, et al.
U.S. Appl. No. 10/598,887, filed Sep. 14, 2006, Busch-Peterson, et al.
U.S. Appl. No. 10/598,885, filed Sep. 14, 2006, Busch-Peterson, et al.
U.S. Appl. No. 10/598,882, filed Sep. 14, 2006, Busch-Peterson, et al.
U.S. Appl. No. 10/599,717, filed Oct. 6, 2006, Laine, et al.
U.S. Appl. No. 11/568,330, filed May 3, 2007, Laine, et al.
U.S. Appl. No. 11/568,930, filed Nov. 10, 2006, Laine, et al.
U.S. Appl. No. 11/568,909, filed Nov. 10, 2006, Palovich, et al.
U.S. Appl. No. 11/570,981, filed Dec. 20, 2006, Cooper, et al.
U.S. Appl. No. 11/573,097, filed Feb. 2, 2007, Busch-Peterson, et al.
U.S. Appl. No. 11/573,099, filed Feb. 2, 2007, Busch-Peterson, et al.
Sarau,Mol. Pharmacol., vol. 56 (3) p. 657-63 (1999).
Van Rossumm, et al.,Arch. Int. Pharmacodyn., vol. 143 p. 299 (1963) Best Available Copy.
Zhang, et al.,J Med Chem, vol. 44 pp. 3937-3945 (2001).
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984), with translation.
Wu, et al.,Zhongguo Yaowu Huaxue Zazhi, vol. 3(1) pp. 23-26 (1993), with translation.
Yu, et al.,Yaoxue Xuebao, vol. 18(10) pp. 766-774 (1983), with translation.
Zhang, et al.,Yaoxue Xuebao, vol. 20(10) pp. 752-758 (1985), with translation.
Brown,History and Basic Properties, Humana Press, USA pp. 7-9 (1989).
Caulfield,Pharmac. Ther., vol. 58 pp. 319-379 (1993).
Costello, et al.,American Journal of Physiology, vol. 276 (5) pp. L709-L714 (1999).
Fryer and Jacoby,Am J Respir Crit Care Med, vol. 158 (5, pt 3) pp. 154-160 (1998).
Fryer et al.,Life Sci, vol. 64 (6-7) pp. 449-455 (1999).
Hegke, et al.,Life Sciences, vol. 64 (6/7) pp. 419-428 (1999).
Ikeda, et al.,Naunyn-Schmiedeberg's Arch Pharmacol., vol. 366, pp. 97-103, (2002).
Minette, et al.,Journal of Applied Physiology, vol. 67(6) pp. 2461-2465 (1989).
Oprins, et al.,Annals of the New York Academy of Sciences, vol. 915 pp. 102-106 (2000).
Pauwels et al.,Am. J. Respir. Crit. Care Med., vol. 163 pp. 1256-1276 (2001).
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984) Abstract only.
Wu, et al.,Zhongguo Yaowu Huazue Zazhi, vol. 3 (1) pp. 223-26 (1993)Abstract only.
Zirkle, et al.,J Med Chem, vol. 27 pp. 1269-1279 (1962).
Zirkle, et al.,J Med Chem, vol. 27 pp. 1279-1285 (1962).
Zirkle, et al.,J Med Chem, vol. 5 pp. 341-356 (1962).
Busch-Petersen Jakob
Palovich Michael R.
Wan Zehong
Yan Hongxing
Zhu Chongjie
Dinner Dara L.
Glaxo Group Limited
Kinzig Charles M.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Muscarinic acetylcholine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic acetylcholine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic acetylcholine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088340